Interim Results of the Dropless Pars Plana Vitrectomy Study

Related

• 

  APX3330, an Oral Drug in Trial for DR and DME, Demonstrated a Favorable Safety and Tolerability Profile in Multiple Phase 1 and 2 Studies

  Michael J Allingham, MD, PhD

  Annual Meeting Talks

  2021

• 

  Bimanual IOL Rescue

  Deval D Joshi, MD

  Jonathan A. Feistmann, MD

  Shaminder Singh Bhullar, MD

  Innovative Retina Surgical Video Series

  2013

• 

  Hypersonic Vitrectomy

  Carl C. Awh, MD, FASRS

  Updates from the Field

  2017